levodopa/carbidopa fairmed 100 mg/25 mg tabletes
fairmed healthcare gmbh, germany - levodopum, carbidopum - tablete - 100 mg/25 mg
levodopa/carbidopa fairmed 250 mg/25 mg tabletes
fairmed healthcare gmbh, germany - levodopum, carbidopum - tablete - 250 mg/25 mg
gabapentin strides 100 mg cietās kapsulas
strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 100 mg
gabapentin strides 300 mg cietās kapsulas
strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 300 mg
gabapentin strides 400 mg cietās kapsulas
strides pharma (cyprus) limited, cyprus - gabapentīns - kapsula, cietā - 400 mg
alfacalcidol strides pharma 0,25 mikrogrami mīkstās kapsulas
strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 0,25 µg
alfacalcidol strides pharma 0,5 mikrogrami mīkstās kapsulas
strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 0,5 µg
alfacalcidol strides pharma 1 mikrograms mīkstās kapsulas
strides pharma (cyprus) limited, cyprus - alfakalcidols - kapsula, mīkstā - 1 µg
kauliv
strides pharma (cyprus) limited - teriparatide - osteoporosis; osteoporosis, postmenopausal - kalcija homeostāze - kauliv is indicated in adults. treatment of osteoporosis in postmenopausal women and in men at increased risk of fracture (see section 5. in postmenopausal women, a significant reduction in the incidence of vertebral and non-vertebral fractures but not hip fractures has been demonstrated. treatment of osteoporosis associated with sustained systemic glucocorticoid therapy in women and men at increased risk for fracture (see section 5.
sorafenib accord
accord healthcare s.l.u. - sorafenib tosilate - carcinoma, hepatocellular; carcinoma, renal cell - antineoplastiski līdzekļi - hepatocellular carcinomasorafenib accord is indicated for the treatment of hepatocellular carcinoma (see section 5. renal cell carcinomasorafenib accord is indicated for the treatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.